Phosphorylation of insulin-like growth factor binding proteins

Molecular and Cellular Endocrinology

Volumn 128, Issue 1-2, 1997, Pages 1-5

  Coverley, J A ^a   Baxter, R C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Insulin like growth factor binding protein; Kinase; Phosphoprotein; Phosphorylation

Indexed keywords

CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHOPROTEIN; PROTEIN KINASE C; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5;

ARTICLE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 0030988934     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)04032-X     Document Type: Article

References (25)

1. Cohen, P. (1985) The role of protein phosphorylation in the hormonal control of enzyme activity. Eur. J. Biochem. 151, 439-448.
2. Cohen, P. (1992) Signal integration at the level of protein kinases, protein phosphatases and their substrates. Trends Biochem. Sci. 17, 408-413.
3. Roach, P.J. (1991) Multisite and hierarchal protein phosphorylation. J. Biol. Chem. 266, 14 139-14 142.
4. Baxter, R.C. (1996) Molecular aspects of insulin-like growth factor binding proteins. In: Advances in Molecular and Cellular Endocrinology, (LeRoith, D. ed.), Vol. 1, pp. 123-159, JAI Press, Greenwich.
5. Baxter, R.C. (1993) Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol. Metab. 4, 91-96.
6. Jones, J.I. and Clemmons, D.R. (1995) Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev. 16, 3-34.
7. Jones, J.I., D'Ercole, A.J., Camacho-Hubner, C. and Clemmons, D.R. (1991) Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I. Proc. Natl. Acad. Sci. USA 88, 7481-7485.
8. Hoeck, W.G. and Mukku, V.R. (1994) Identification of the major sites of phosphorylation in IGF binding protein-3. J. Cell. Biochem. 56, 262-273.
9. Jones, J.I., Gockerman, A. and Clemmons, D.R. (1992) Insulin-like growth factor binding protein-5 (IGFBP-5) binds to extracellular matrix and is phosphorylated. Abstracts, 74th Annual Meeting, The Endocrine Society, San Antonio, Texas, pp. 372.
10. Issinger, O.-G. (1993) Casein kinases: Pleiotropic mediators of cellular regulation. Pharm. Ther. 59, 1-30.
11. Nishida, E. and Gotoh, Y. (1993) The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 18, 128-131.
12. Busby, W.H., Klapper, D.G. and Clemmons, D.R. (1988) Purification of a 31,000 Dalton insulin-like growth factor binding protein from human amniotic fluid. J. Biol. Chem. 263, 14 203-14 210.
13. Jones, J.I., Busby, W.H., Wright, G., Smith, C.E., Kimack, N.M. and Clemmons, D.R. (1993) Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1: Regulation of its affinity by phosphorylation of serine 101. J. Biol. Chem. 268, 1125-1131.
14. Koistinen, R., Angervo, M., Leinonen, P., Hakala, T. and Seppala, M. (1993) Phosphorylation of insulin-like growth factor binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. Clin. Chim. Acta 215, 189-199.
15. Jyung, R.W., Mustoe, J.A., Busby, W.H. and Clemmons, D.R. (1994) Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Surgery 115, 233-239.
16. Frost, R.A., Bereket, A., Wilson, T.A., Wojnar, M.M., Lang, C.H. and Gelato, M.C. (1994) Phosphorylation of insulin-like growth factor binding protein-1 in patients with insulin-dependent diabetes mellitus and severe trauma. J. Clin. Endocrinol. Metab. 78, 1533-1535.
17. Frost, R.A., Fuhrer, J., Steigbigel, R., Mariuz, P., Lang, C.H. and Gelato, M.C. (1996) Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin. Endocrinol. 44, 501-514.
18. Westwood, M., Gibson, J.M., Davies, A.J., Young, R.J. and White, A. (1994) The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J. Clin. Endocrinol. Metab. 79, 1735-1741.
19. Baxter, R.C., Hizuka, N., Takano, K., Holman, S.R. and Asakawa, K. (1993) Responses of insulin-like growth factor binding protein-1 (IGFBP-1) and the IGFBP-3 complex to administration of insulin-like growth factor-I. Acta Endocrinol. 128, 101-108.
20. Cotterill, A.M., Cowell, C.T., Baxter, R.C., McNeil, D. and Silink, M. (1988) Regulation of the growth hormone-independent growth factor binding protein in children. J. Clin. Endocrinol. Metab. 67, 882-887.
21. Mukku, V.R., Chu, H. and Baxter, R. (1991) Insulin-like growth factor binding protein, IGFBP-3 is secreted as a phosphoprotein. Abstracts, 2nd Int. IGF Symp., San Francisco, California, pp. 237.
22. Baxter, R.C. and Firth, S.M. (1995) Modulation of human IGF binding protein-3 activity by structural modification. Prog. Growth Factor Res. 6, 215-222.
23. Coverley, J.A. and Baxter, R.C. (1995) Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I. Endocrinology 136, 5778-5781.
24. Martin, J.L., Ballesteros, M. and Baxter, R.C. (1992) Insulin-like growth factor-I (IGF-I) and transforming growth factor β1 release IGF-binding protein-3 from fibroblasts by different mechanisms. Endocrinology 131, 1703-1710.
25. Valentinis, B., Bhala, A., DeAngelis, T., Baserga, R. and Cohen, P. (1995) The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 9, 361-367.